The incidence of prostate cancer varies based on geographic regions, with higher rates observed in developed regions, likely due to increased screening and the availability of diagnostic tools such as prostate-specific antigen (PSA) testing [5,6,7]. This evidence concerns the gene KLK3 and prostate cancer.